Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
Suksawat M, Phetcharaburanin J, Klanrit P, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Vilayhong V, Sa-Ngiamwibool P, Techasen A, Wangwiwatsin A, Mahalapbutr P, Li JV, Loilome W.
Suksawat M, et al. Among authors: wangwiwatsin a.
Front Public Health. 2022 Feb 10;10:766023. doi: 10.3389/fpubh.2022.766023. eCollection 2022.
Front Public Health. 2022.
PMID: 35223723
Free PMC article.